Retinal abnormalities as biomarker of disease progression and early diagnosis of Parkinson disease

Brief description of study

The purpose of this study is to determine if there are abnormalities in the eye structure of patients that have difficulty with controlling movement and/or blood pressure and to investigate whether changes in eye structure can be used to differentiate between neurological conditions and determine disease progression. This study is being sponsored by the Michael J. Fox Foundation for Parkinson’s research.


Clinical Study Identifier: s15-01391
ClinicalTrials.gov Identifier: NCT02640339
Principal Investigator: Horacio Kaufmann
Currently Recruiting

Contact the research team to learn more about this study.


By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.